The outlook for the stock of Jubilant Life Sciences is bearish. The stock fell 3 per cent on Monday. The stock has been in a strong downtrend since March high of ₹451.8. This fall halted at a low of ₹339.5 in May. The corrective rally from this low faced strong resistance from the 200-DMA at ₹377.
After consolidating below this resistance for about a week, the stock tumbled sharply this week. Monday’s strong fall keeps the overall downtrend intact and also signals the beginning of a fresh leg of down move.
Strong resistance is in ₹363-364 band. . Traders with a short-term perspective can go short. Stop-loss can be placed at ₹358 for a target of ₹335. Revise the stop-loss lower to ₹345 as soon as the stock slips to ₹340.
The outlook for the stock will turn positive only if it breaches above the 200-DMA resistance decisively. But such a strong up move looks unlikely at the moment.
(Note: The recommendations are based on technical analysis. There is a risk of loss in trading.)
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.